Renaissance Technologies (RenTech)'s VHT Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 16,120 shares of Vanguard Health Care ETF (VHT) worth $4.82 M, representing 0.01% of the portfolio. First purchased in 2018-Q1, this long-term strategic position has been held for 26 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in VHT, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2026, adding 16,120 shares. Largest reduction occurred in Q1 2026, reducing 13,560 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Vanguard Health Care ETF (VHT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Vanguard Health Care ETF (VHT) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +16,120 | New Buy | 16,120 | $299.01 |
| Q1 2026 | -13,560 | Sold Out | 0 | $0.00 |
| Q4 2025 | +8,160 | Add 151.11% | 13,560 | $287.85 |
| Q3 2025 | -4,900 | Reduce 47.57% | 5,400 | $259.60 |
| Q2 2025 | +10,300 | New Buy | 10,300 | $248.34 |
| Q1 2025 | -2,500 | Sold Out | 0 | $0.00 |
| Q4 2024 | -800 | Reduce 24.24% | 2,500 | $253.69 |
| Q3 2024 | +3,300 | New Buy | 3,300 | $282.20 |
| Q2 2024 | -3,700 | Sold Out | 0 | $0.00 |
| Q1 2024 | +3,700 | New Buy | 3,700 | $270.54 |
| Q3 2023 | -900 | Sold Out | 0 | $0.00 |
| Q2 2023 | -7,700 | Reduce 89.53% | 900 | $0.24 |
| Q1 2023 | +8,600 | New Buy | 8,600 | $0.24 |
| Q4 2022 | -1,200 | Sold Out | 0 | $0.00 |
| Q3 2022 | +1,200 | New Buy | 1,200 | $223.33 |
| Q2 2021 | -5,300 | Sold Out | 0 | $0.00 |
| Q1 2021 | +5,300 | New Buy | 5,300 | $228.68 |
| Q3 2020 | -5,200 | Sold Out | 0 | $0.00 |
| Q2 2020 | +5,200 | New Buy | 5,200 | $192.69 |
| Q1 2020 | -4,200 | Sold Out | 0 | $0.00 |
| Q4 2019 | +4,200 | New Buy | 4,200 | $191.67 |
| Q3 2019 | -2,300 | Sold Out | 0 | $0.00 |
| Q2 2019 | -5,600 | Reduce 70.89% | 2,300 | $173.91 |
| Q1 2019 | +7,900 | New Buy | 7,900 | $172.53 |
| Q2 2018 | -1,700 | Sold Out | 0 | $0.00 |
| Q1 2018 | +1,700 | New Buy | 1,700 | $153.53 |
Renaissance Technologies (RenTech)'s Vanguard Health Care ETF Investment FAQs
Renaissance Technologies (RenTech) first purchased Vanguard Health Care ETF (VHT) in Q1 2018, acquiring 1,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Vanguard Health Care ETF (VHT) for 26 quarters since Q1 2018.
Renaissance Technologies (RenTech)'s largest addition to Vanguard Health Care ETF (VHT) was in Q2 2026, adding 16,120 shares worth $4.82 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 16,120 shares of Vanguard Health Care ETF (VHT), valued at approximately $4.82 M.
As of the Q2 2026 filing, Vanguard Health Care ETF (VHT) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Vanguard Health Care ETF (VHT) was 16,120 shares, as reported at the end of Q2 2026.